• As we discussed in our previous blogs, transitioning to molecular diagnostic PCR testing in other infection categories — particularly as COVID-19 testing slows down — is an important and practical next step in driving revenue growth and in making molecular diagnostic PCR testing the preferred […]

    Continue reading